StockWatch
·
KALPATARU LTD · QQ2 FY-2027 · THE CALL

Profits papered by project completion method; pre-sales momentum slowing

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsKALPATARUKalpataru Ltd02 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade C

FY27 pre-sales guidance maintained at ₹6.5k but pre-sales down 5% YoY in Q2. Net debt/equity worsened (2.1x vs 2.0x). H2 execution risk.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Kalpataru's H1 delivered a loss of ₹71 Cr and 45% revenue decline, driven by project completion method timing and cost pressures (OPM -23.6%). Pre-sales slowed 5% YoY in Q2, narrowing the path to ₹6.5k guidance. Management claims demand is healthy but pre-sales data contradicts this. The 14M sqft completion pipeline (5.5M in FY27) offers upside, but net debt/equity worsened to 2.1x vs prior 2.0x guidance.

₹437.2 Cr

Revenue · −44.9% YoY

₹-70.7 Cr

Reported PAT · −1524.8% YoY

Compressing

Margins · vs guidance: Overstated

Did the claims hold up?

Management's claims vs. the numbers

Pre-sales momentum strong; demand healthy across spectrum

MISS

Q2 pre-sales ₹1,258 Cr down 5% YoY; H1 flat YoY. Kalpataru Park City 130% growth masks overall decline.

On track for 6.5k pre-sales guidance

OVERSTATED

₹2,587 Cr (40%) achieved H1; need ₹3,913 Cr (60%) in H2 as Q2 momentum slowed 5% YoY.

Net debt guidance flat to FY26; ratio to improve

MISS

Net debt/equity 2.1x now vs 2.0x prior. Ratio worsened; guidance not met.

H1 completions on track for 5.5M sqft FY27 target

MET

2.37M sqft delivered in H1; 3.13M sqft remaining for H2. Execution track record strong.

Operating margin 16.6% EBITDA, projects will drive profits in H2

MET

Q2 PAT loss ₹71 Cr, NPM -14.7%. Profit recognition timing issue, not operational recovery.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Pre-sales momentum decelerated

Downgrade

Q2 FY27 ₹1,258 Cr down 5% YoY vs FY26. H1 flat YoY (₹2,587 Cr). Prior call implied growth; actual is contraction.

Net debt/equity worsened

Downgrade

2.1x vs 2.0x prior guidance. Prior call stated ratio would improve from 2.0x; guidance not met.

Margin compression

Downgrade

Q2 OPM -23.6%, NPM -14.7%; operating loss ₹71 Cr. FY26 was profitable; now in loss.

Project completion pipeline affirmed

Neutral

14M sqft over FY27-29 with 5.5M in FY27 (2.37M done in H1) remains on track. Profit recognition mechanism unchanged.

The Q&A

Analysts pressed lightly on pre-sales bridge, launch delays, and net debt. Management deflected pre-sales momentum concerns by citing historical 40/60 H1/H2 split and claiming demand is "healthy everywhere." No hard pushback on margin collapse or debt deterioration.

The exchanges that mattered

Pre-sales guidance bridge — Sourabh Gilda, JM Financial

Answered

Sustenance sales from ongoing projects + 3 launches (Chembur, Pune, Nagpur). Festive period Oct-Mar will drive. 40/60 is historical trend we've met.

Launch approval status — Sourabh Gilda, JM Financial

Answered

Suman Nagar: IOD received, Q4 launch. Nagpur: pre-approval done, final in 1.5 months, Q4. Blossoms: RERA applied, launch before Dec.

Demand across segments — Sourabh Gilda, JM Financial

Partial

Demand healthy across everywhere. Under ₹3 Cr strong (Thane, Mira Road, Pune). Western Mumbai launches saw good response. Luxury (SoBo) good walk-in and interest.

Net debt guidance — Vishal Singh, individual investor

Partial

Guidance for net debt at year-end will remain flat, as compared to FY 2026. Focus on execution and capex spend.

Pre-sales execution risk — Vishal Singh, individual investor

Dodged

Guidance remains ₹6.5k. Good pipeline of launches and sustenance sales. Focused on execution.

Project delays and approvals — Ashi, MyCel Advisors

Answered

Three projects (Chembur, Pune, Nagpur). All on track for Q3/Q4 launch.

Price hikes and inflation — Ashi, MyCel Advisors

Answered

3-5% price rise across projects. Covers inflation and anticipated costs. Good headroom for future.

Guidance

Forward guidance and management's confidence

Pre-sales FY27 ₹6,500 Cr (23% growth)

Medium

₹2,587 Cr (40%) achieved H1; need ₹3,913 Cr (60%) in H2. Q2 down 5% YoY.

Project completion method; H2 completions drive profit recognition

Medium

5.5M sqft completions in FY27. Profits timing-driven; Q2 loss of ₹71 Cr now.

Focus on project execution and capital deployment

Medium

14M sqft pipeline over FY27-29; sustains growth capex.

Risks the call surfaced

Ranked by how much they should concern a holder

Pre-sales execution risk

High

Q2 pre-sales ₹1,258 Cr down 5% YoY. Need ₹3.9k Cr (60%) in H2 to achieve ₹6.5k guidance. Q2 momentum slowing; management's "demand healthy" claim contradicted by data.

Margin compression and cash burn

High

Q2 loss of ₹71 Cr, OPM -23.6%, NPM -14.7%. Revenue down 45% YoY while cost structure inflexible. Working capital consumed despite ₹437 Cr revenue.

Debt and balance sheet deterioration

Medium

Net debt/equity 2.1x vs prior guidance of improvement from 2.0x. Gross debt ₹9,179 Cr, net debt ₹8,323 Cr. Guidance for flat debt likely unmet.

Macro slowdown transmission

Medium

Management admits "macro environment continued to be challenging for a second quarter in a row." Pre-sales down 5% YoY despite claims of healthy demand.

Execution and approval delays

Low

3 key launches (Chembur, Pune, Nagpur) still awaiting final approvals/RERA. Delays could push sales into FY28.

Management

Score 6/10. Structured and organized (clear split between ops & finance speakers), but selective on transparency. Frames 40/60 H1/H2 as a trend to justify H2 guidance, but Q2 momentum slowing makes this aspirational. Vague on debt (claimed "flat" when 2.1x > 2.0x). Doesn't address margin collapse directly. Strong on project delivery (2.37M sqft delivered H1, on track for 5.5M target). Pre-sales track record mixed: H1 flat YoY; Q2 down 5% vs ₹6.5k guidance which requires 60% in H2. Launches (Elaara 30% sold, Vian ongoing) show some momentum but not enough to offset overall slowness.

What to watch next
  • 1 · Q3 FY27 (Dec 2026)

    Launch Suman Nagar, Chembur; Ardene, Nagpur; Blossoms, Pune

  • 2 · H2 FY27 (Jan-Mar 2027)

    5.5M sqft completions recognize 14M sqft pipeline profits over FY27-29

  • 3 · H2 FY27

    Festive season sustenance sales to bridge ₹3.9k Cr pre-sales gap

The 14M sqft completion pipeline (5.5M in FY27) offers upside, but net debt/equity worsened to 2.1x vs prior 2.0x guidance.

Informational and educational content only. Not investment advice.